Rukobia 600 mg prolonged-release tablets

Licence status
Authorised: 04/02/2021
Active substances
Fostemsavir Tromethamine
Dosage Form
Prolonged-release tablet
Licence number
EU/1/20/1518/001
Licence holder
ViiV Healthcare BV

Product documents

Licence information

ATC code
J05AX29 fostemsavir
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
04/02/2021